Cancer treatment has advanced substantially with the development of molecularly targeted and immune-based approaches that aim to improve therapeutic selectivity and reduce treatment-related toxicity. This review summarises selected emerging technologies in cancer treatment, inclu...
Open access
Research Article10.9734/jcti/2026/v16i3364
Background: Chimeric antigen receptor T-cell (CAR T-cell) therapy has revolutionised cancer treatment, particularly for relapsed or refractory haematological malignancies. However, treatment-related toxicities, including tumour lysis syndrome (TLS), remain a significant concern....
Open access
Research Article10.9734/jcti/2026/v16i3363
Aim: This study assessed the epidemiological profile, treatment modalities, and treatment outcomes of childhood malignancies managed at Korle Bu Teaching Hospital, Ghana, from 2019 to 2023. Study Design: A retrospective cross-sectional study was conducted. Place and Duration of S...
Open access
Research Article10.9734/jcti/2026/v16i3362
Hameida Elfarssi, Nagwa Ali, Hajer S. Mohammed, Aya Mansour Elzagheibi, Sara Salem Elmoghrab, Amera Musa Elhothiry & Ekhlas Mohsen Elmahjoub·Journal of Cancer and Tumor International·2026
Background: Childhood cancer remains a major global health concern, with treatment-related nutritional complications significantly affecting outcomes and quality of life despite survival rates improving. Parents of children with cancer face significant emotional, psychological, a...
Open access
Research Article10.9734/jcti/2026/v16i3361
Advanced-stage ovarian cancer is characterized by high mortality and frequent peritoneal recurrence. “Hyperthermic Intraperitoneal Chemotherapy” (HIPEC), which delivers heated chemotherapeutic agents directly into the peritoneal cavity following cytoreductive surgery (CRS), aims...
Open access
Research Article10.9734/jcti/2026/v16i3360
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder characterised by isolated thrombocytopenia (platelet count <100 × 10⁹/L) and bleeding manifestations. While primary ITP is common, secondary ITP associated with solid organ malignancies is a rare and chal...
Open access
Research Article10.9734/jcti/2026/v16i3359
Background: Glioblastoma is the most aggressive primary malignant brain tumor in adults and is associated with poor prognosis despite advances in surgical and adjuvant therapies. Extent of resection (EOR) has emerged as a critical prognostic factor influencing survival outcomes;...
Open access
Research Article10.9734/jcti/2026/v16i3358
Jean Paul Engbang, Ambroise Ntama, Henry Essome, Esther Dina Bell Mbassi, Charlotte Nguefack Tchente & Zacharie Sando·Journal of Cancer and Tumor International·2026
Background: Breast cancer is the leading malignancy among women in Cameroon, yet national decision-making still relies heavily on international estimates, isolated hospital series and incompletely documented registries. This limitation weakens the interpretation of incidence, pre...
Open access
Research Article10.9734/jcti/2026/v16i3357
Background: Colorectal cancer is the fourth most common cancer and the second largest cause of cancer mortality in the United Kingdom. According to World Health Organization, there were 1.8 million new cases and almost 861,000 deaths in 2018, globally. In United Kingdom over 42,0...
Open access
Research Article10.9734/jcti/2026/v16i2356
Background: Colorectal cancer (CRC) poses an escalating public health challenge in Nigeria, characterised by late-stage clinical presentations and high mortality rates. While screening remains the most effective intervention for mitigating disease progression, national uptake rem...
Open access
Research Article10.9734/jcti/2026/v16i2355